T F Pajak

1.1k total citations
27 papers, 878 citations indexed

About

T F Pajak is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, T F Pajak has authored 27 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 7 papers in Surgery. Recurrent topics in T F Pajak's work include Head and Neck Cancer Studies (6 papers), Multiple Myeloma Research and Treatments (3 papers) and Cancer Treatment and Pharmacology (3 papers). T F Pajak is often cited by papers focused on Head and Neck Cancer Studies (6 papers), Multiple Myeloma Research and Treatments (3 papers) and Cancer Treatment and Pharmacology (3 papers). T F Pajak collaborates with scholars based in United States, France and Puerto Rico. T F Pajak's co-authors include Muhyi Al‐Sarraf, Jay S. Cooper, Richard Caplan, James D. Cox, Phyllis J. Ager, Arnold Herskovic, Majid Mohiuddin, Deborah R. Davis, O. Ross McIntyre and Chu H. Chang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

T F Pajak

25 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T F Pajak United States 17 340 279 261 260 133 27 878
É. Luporsi France 19 545 1.6× 292 1.0× 232 0.9× 167 0.6× 116 0.9× 66 1.0k
George Plataniotis Greece 16 352 1.0× 238 0.9× 247 0.9× 195 0.8× 103 0.8× 40 1.1k
John Showel United States 13 397 1.2× 398 1.4× 315 1.2× 520 2.0× 65 0.5× 23 1.0k
R. Semrau Germany 23 493 1.4× 564 2.0× 478 1.8× 408 1.6× 125 0.9× 59 1.3k
James D. Cox United States 18 415 1.2× 249 0.9× 213 0.8× 150 0.6× 406 3.1× 23 1.1k
C. Norman Coleman United States 15 226 0.7× 140 0.5× 241 0.9× 66 0.3× 332 2.5× 25 780
Parvesh Kumar United States 20 423 1.2× 364 1.3× 540 2.1× 506 1.9× 91 0.7× 43 1.2k
Jiřı́ Petera Czechia 18 344 1.0× 291 1.0× 369 1.4× 65 0.3× 70 0.5× 108 969
E. Sandberg Denmark 10 382 1.1× 221 0.8× 163 0.6× 90 0.3× 75 0.6× 17 749
Frank Chi Sing Wong China 16 548 1.6× 591 2.1× 325 1.2× 575 2.2× 68 0.5× 40 1.3k

Countries citing papers authored by T F Pajak

Since Specialization
Citations

This map shows the geographic impact of T F Pajak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T F Pajak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T F Pajak more than expected).

Fields of papers citing papers by T F Pajak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T F Pajak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T F Pajak. The network helps show where T F Pajak may publish in the future.

Co-authorship network of co-authors of T F Pajak

This figure shows the co-authorship network connecting the top 25 collaborators of T F Pajak. A scholar is included among the top collaborators of T F Pajak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T F Pajak. T F Pajak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pajak, T F, Andy Trotti, Clement K. Gwede, et al.. (2005). The TAME Risk Classification System: Acute Toxicity Burden and IPD Analysis of RTOG 90–03. International Journal of Radiation Oncology*Biology*Physics. 63. S131–S131. 1 indexed citations
2.
Riese, Nancy, et al.. (1997). Pharmacokinetic monitoring and dose modification of Etanidazole in the RTOG 85-27 phase III head and neck trial. International Journal of Radiation Oncology*Biology*Physics. 39(4). 855–858. 12 indexed citations
3.
Al‐Sarraf, Muhyi, T F Pajak, Roger W. Byhardt, et al.. (1997). Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24. International Journal of Radiation Oncology*Biology*Physics. 37(4). 777–782. 62 indexed citations
4.
Sedransk, J., et al.. (1997). National averages for process and outcome in radiation oncology: Methodology of the Patterns of Care Study. Seminars in Radiation Oncology. 7(2). 101–107. 40 indexed citations
5.
Nag, Subir, Jean B. Owen, Nancy Farnan, et al.. (1995). Survey of brachytherapy practice in the United States: A report of the Clinical Research Committee of the American Endocurietherapy Society. International Journal of Radiation Oncology*Biology*Physics. 31(1). 103–107. 20 indexed citations
6.
Sause, William T., T F Pajak, R. Dirk Noyes, et al.. (1994). Evaluation of Preoperative Radiation Therapy in Operable Colorectal Cancer. Annals of Surgery. 220(5). 668–675. 25 indexed citations
7.
Caplan, Richard, T F Pajak, & James D. Cox. (1994). Analysis of the probability and risk of cause-specific failure. International Journal of Radiation Oncology*Biology*Physics. 29(5). 1183–1186. 84 indexed citations
8.
Komaki, Ritsuko, T F Pajak, Roger W. Byhardt, et al.. (1993). Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433. Lung Cancer. 10(3-4). 189–197. 11 indexed citations
9.
John, Markus R., Marshall S. Flam, T F Pajak, et al.. (1993). Is mitomycin-c necessary in the chemoradiation regimen for anal canal carcinoma? interim results of a phase III randomized intergroup study. International Journal of Radiation Oncology*Biology*Physics. 27. 245–245.
10.
Jacobs, John R., K.K. Fu, Louis D. Lowry, et al.. (1991). 5-Year Results of Cisplatin and Fluorouracil Infusion in Head and Neck Cancer. Archives of Otolaryngology - Head and Neck Surgery. 117(3). 288–291. 21 indexed citations
11.
Al‐Sarraf, Muhyi, T F Pajak, Jay S. Cooper, et al.. (1990). Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study.. Journal of Clinical Oncology. 8(8). 1342–1351. 115 indexed citations
12.
Wallner, Paul E., Robert A. Lustig, T F Pajak, et al.. (1989). Impact of initial quality control review on study outcome in lung and head/neck cancer studies—review of the radiation therapy oncology group experience. International Journal of Radiation Oncology*Biology*Physics. 17(4). 893–900. 28 indexed citations
13.
Schuller, Dorit Elisabeth, et al.. (1989). Combined Therapy for Resectable Head and Neck Cancer: A Phase 3 Intergroup Study. Archives of Otolaryngology - Head and Neck Surgery. 115(3). 364–368. 11 indexed citations
14.
Cornwell, Gibbons G., T F Pajak, S Kochwa, et al.. (1988). Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experience.. Journal of Clinical Oncology. 6(9). 1481–1490. 5 indexed citations
15.
Cornwell, Gibbons G., T F Pajak, O. Ross McIntyre, S Kochwa, & Harvey Dosik. (1982). Influence of renal failure on myelosuppressive effects of melphalan: Cancer and Leukemia Group B experience.. PubMed. 66(3). 475–81. 39 indexed citations
16.
Bloomfield, C. D., T F Pajak, Arvin S. Glicksman, et al.. (1982). Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies.. PubMed. 66(4). 835–46. 43 indexed citations
17.
Lewis, Jerry P., T F Pajak, James W. Linman, & Joseph R. Bateman. (1981). Maintenance management of acute nonlymphocytic leukemia.. PubMed. 4(2). 115–24. 4 indexed citations
18.
Chlebowski, R. T., et al.. (1980). Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity.. PubMed. 64(1). 47–51. 94 indexed citations
19.
Kyle, Robert A., Salman Gailani, Barbara R. Seligman, et al.. (1979). Multiple myeloma resistant to melphalan: treatment with cyclophosphamide, prednisone, and BCNU.. PubMed. 63(8). 1265–9. 17 indexed citations
20.
Kardinal, Carl G., et al.. (1976). Evaluation of bleomycin, adriamycin, and vinblastine in combination therapy for advanced testicular tumors.. PubMed. 60(7). 953–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by É. Luporsi Breakdown of academic impact, for papers by George Plataniotis Breakdown of academic impact, for papers by John Showel Breakdown of academic impact, for papers by R. Semrau Breakdown of academic impact, for papers by James D. Cox Breakdown of academic impact, for papers by C. Norman Coleman Breakdown of academic impact, for papers by Parvesh Kumar Breakdown of academic impact, for papers by Jiřı́ Petera Breakdown of academic impact, for papers by E. Sandberg Breakdown of academic impact, for papers by Frank Chi Sing Wong
Rankless by CCL
2026